Brilaroxazine (Standard)

Description

Brilaroxazine Standard is the analytical standard of Brilaroxazine. This product is intended for research and analytical applications. Brilaroxazine RP5603 is a potent and orally active multimodal dopamine DA /serotonin 5-HT modulator. Brilaroxazine is a partial agonist of dopamine DA D2, D3, and D4 receptors, 5-HT1A Ki=1.5 nM and 5-HT2A Ki=2.5 nM , and has antagonist activity at 5-HT2B Ki=0.19 nM , and 5-HT7 Ki=2.7 nM receptors. Brilaroxazine is an atypical antipsychotic agent, and has the potential to improve cognitive impairments in neuropsychiatric and neurological diseases in vivo.